HK Stock MarketDetailed Quotes

08189 TEDA BIOMEDICAL

Watchlist

0.280
+0.010+3.70%

Market Closed Nov 28 16:08 CST

530.46MMarket Cap-35000P/E (TTM)

TEDA BIOMEDICAL Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

(Q3)Mar 31, 2022

(FY)Dec 31, 2021

Turnover

13.80%211.57M

-1.42%398M

0.08%305.23M

-9.40%185.92M

-3.11%86.42M

-15.25%403.73M

-14.61%304.97M

-15.13%205.21M

-28.30%89.2M

28.98%476.38M

Operating income

13.80%211.57M

-1.42%398M

0.08%305.23M

-9.40%185.92M

-3.11%86.42M

-15.25%403.73M

-14.61%304.97M

-15.13%205.21M

-28.30%89.2M

28.98%476.38M

Cost of sales

-11.38%-199.45M

3.16%-376.63M

0.02%-293.73M

8.10%-179.07M

0.40%-83.37M

9.72%-388.91M

7.76%-293.78M

8.84%-194.84M

24.37%-83.71M

-30.95%-430.78M

Operating expenses

-11.38%-199.45M

3.16%-376.63M

0.02%-293.73M

8.10%-179.07M

0.40%-83.37M

9.72%-388.91M

7.76%-293.78M

8.84%-194.84M

24.37%-83.71M

-30.95%-430.78M

Gross profit

76.90%12.12M

44.15%21.37M

2.79%11.5M

-33.96%6.85M

-44.40%3.05M

-67.50%14.82M

-71.03%11.19M

-63.05%10.37M

-59.99%5.49M

12.91%45.6M

Selling expenses

-33.65%-7.05M

22.96%-8.1M

25.74%-6.96M

35.00%-5.28M

28.86%-3.03M

39.17%-10.52M

45.01%-9.37M

38.11%-8.12M

45.54%-4.26M

-3.69%-17.29M

Administrative expenses

----

3.93%-21.8M

----

27.87%-22.7M

----

-33.00%-31.47M

Research and development expenses

37.85%-8.56M

-16.09%-1.32M

4.17%-21.54M

-12.51%-13.77M

-3.66%-6.86M

67.52%-1.14M

-19.72%-22.48M

14.27%-12.24M

11.18%-6.62M

36.57%-3.5M

Profit from asset sales

----

--5.91M

----

Impairment and provision

----

-115.00%-11.18M

----

86.25%-5.2M

----

-9.71%-37.84M

-Impairment of intangible assets

----

-17.58%-1.84M

-Impairment of property, machinery and equipment

----

---3.16M

-Goodwill impairment

----

94.74%-420K

-Other impairment is provision

----

-115.00%-11.18M

----

83.96%-5.2M

----

-29.97%-32.42M

Special items of operating profit

87.93%-50.2K

1,120.52%14.2M

-116.09%-467.57K

-261.17%-415.76K

-401.43%-80.09K

-71.75%1.16M

387.72%2.91M

-35.45%257.97K

-81.13%26.57K

163.61%4.12M

Operating profit

71.89%-3.55M

61.26%-6.84M

1.61%-17.47M

-29.65%-12.62M

-28.98%-6.92M

56.27%-17.65M

-620.45%-17.75M

-1,012.47%-9.73M

-278.08%-5.37M

16.00%-40.37M

Financing cost

-29.99%-1.98M

19.19%-5.17M

38.10%-2.54M

54.32%-1.52M

-5.24%-781.54K

-17.09%-6.4M

-189.21%-4.1M

-353.06%-3.33M

-914.12%-742.59K

---5.47M

Share of profits of associates

----

151.64%1M

Adjustment items of earning before tax

----

--2

----

Earning before tax

60.92%-5.53M

50.06%-12.01M

8.46%-20M

-8.24%-14.14M

-26.10%-7.71M

46.35%-24.06M

-1,196.40%-21.85M

-4,041.55%-13.06M

-309.27%-6.11M

10.32%-44.84M

Tax

----

105.86%1.04M

128.30%41.39K

---724

827.00%507.1K

-278.21%-146.28K

-360.02%-146.28K

----

115.08%54.7K

After-tax profit from continuing operations

60.81%-5.53M

53.42%-10.97M

9.26%-19.96M

-6.73%-14.1M

-26.11%-7.71M

47.42%-23.55M

-1,160.09%-22M

-3,507.31%-13.21M

-309.27%-6.11M

11.08%-44.78M

After-tax profit from non-continuing business

----

-129.28%-5.6M

----

---2.44M

----

Earning after tax

60.81%-5.53M

36.25%-16.57M

9.26%-19.96M

-6.73%-14.1M

-26.11%-7.71M

41.96%-25.99M

-1,160.09%-22M

-3,507.31%-13.21M

-309.27%-6.11M

11.08%-44.78M

Minority shareholders should account for profits from continuing business

----

145.81%3.59M

----

--1.46M

----

Minority profit

50.77%-1.4M

145.81%3.59M

-617.87%-2.67M

-7,358.70%-2.85M

-2,595.50%-1.83M

157.73%1.46M

-247.70%-371.67K

109.30%39.23K

94.89%-67.91K

-6.95%-2.53M

Shareholders should account for profits from continuing business

----

41.79%-14.56M

----

---25.01M

----

Shareholders should account for profits from non-continuing business

----

-129.28%-5.6M

----

---2.44M

----

Profit attributable to shareholders

63.35%-4.12M

26.56%-20.16M

20.03%-17.29M

15.08%-11.25M

2.76%-5.88M

35.03%-27.45M

-1,286.00%-21.63M

-1,736.47%-13.25M

-3,548.93%-6.04M

11.97%-42.26M

Basic earnings per share

62.71%-0.0022

26.90%-0.0106

20.18%-0.0091

15.71%-0.0059

3.13%-0.0031

34.98%-0.0145

-1,240.00%-0.0114

-1,850.00%-0.007

-3,100.00%-0.0032

11.86%-0.0223

Diluted earnings per share

26.90%-0.0106

-0.0145

Currency Unit

CNY

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Fan Chen Certified Public Accountants Co., Ltd.

	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022	(Q3)Mar 31, 2022	(FY)Dec 31, 2021
Turnover	13.80%211.57M	-1.42%398M	0.08%305.23M	-9.40%185.92M	-3.11%86.42M	-15.25%403.73M	-14.61%304.97M	-15.13%205.21M	-28.30%89.2M	28.98%476.38M
Operating income	13.80%211.57M	-1.42%398M	0.08%305.23M	-9.40%185.92M	-3.11%86.42M	-15.25%403.73M	-14.61%304.97M	-15.13%205.21M	-28.30%89.2M	28.98%476.38M
Cost of sales	-11.38%-199.45M	3.16%-376.63M	0.02%-293.73M	8.10%-179.07M	0.40%-83.37M	9.72%-388.91M	7.76%-293.78M	8.84%-194.84M	24.37%-83.71M	-30.95%-430.78M
Operating expenses	-11.38%-199.45M	3.16%-376.63M	0.02%-293.73M	8.10%-179.07M	0.40%-83.37M	9.72%-388.91M	7.76%-293.78M	8.84%-194.84M	24.37%-83.71M	-30.95%-430.78M
Gross profit	76.90%12.12M	44.15%21.37M	2.79%11.5M	-33.96%6.85M	-44.40%3.05M	-67.50%14.82M	-71.03%11.19M	-63.05%10.37M	-59.99%5.49M	12.91%45.6M
Selling expenses	-33.65%-7.05M	22.96%-8.1M	25.74%-6.96M	35.00%-5.28M	28.86%-3.03M	39.17%-10.52M	45.01%-9.37M	38.11%-8.12M	45.54%-4.26M	-3.69%-17.29M
Administrative expenses	----	3.93%-21.8M	----	----	----	27.87%-22.7M	----	----	----	-33.00%-31.47M
Research and development expenses	37.85%-8.56M	-16.09%-1.32M	4.17%-21.54M	-12.51%-13.77M	-3.66%-6.86M	67.52%-1.14M	-19.72%-22.48M	14.27%-12.24M	11.18%-6.62M	36.57%-3.5M
Profit from asset sales	----	----	----	----	----	--5.91M	----	----	----	----
Impairment and provision	----	-115.00%-11.18M	----	----	----	86.25%-5.2M	----	----	----	-9.71%-37.84M
-Impairment of intangible assets	----	----	----	----	----	----	----	----	----	-17.58%-1.84M
-Impairment of property, machinery and equipment	----	----	----	----	----	----	----	----	----	---3.16M
-Goodwill impairment	----	----	----	----	----	----	----	----	----	94.74%-420K
-Other impairment is provision	----	-115.00%-11.18M	----	----	----	83.96%-5.2M	----	----	----	-29.97%-32.42M
Special items of operating profit	87.93%-50.2K	1,120.52%14.2M	-116.09%-467.57K	-261.17%-415.76K	-401.43%-80.09K	-71.75%1.16M	387.72%2.91M	-35.45%257.97K	-81.13%26.57K	163.61%4.12M
Operating profit	71.89%-3.55M	61.26%-6.84M	1.61%-17.47M	-29.65%-12.62M	-28.98%-6.92M	56.27%-17.65M	-620.45%-17.75M	-1,012.47%-9.73M	-278.08%-5.37M	16.00%-40.37M
Financing cost	-29.99%-1.98M	19.19%-5.17M	38.10%-2.54M	54.32%-1.52M	-5.24%-781.54K	-17.09%-6.4M	-189.21%-4.1M	-353.06%-3.33M	-914.12%-742.59K	---5.47M
Share of profits of associates	----	----	----	----	----	----	----	----	----	151.64%1M
Adjustment items of earning before tax	----	----	----	----	----	----	----	--2	----	----
Earning before tax	60.92%-5.53M	50.06%-12.01M	8.46%-20M	-8.24%-14.14M	-26.10%-7.71M	46.35%-24.06M	-1,196.40%-21.85M	-4,041.55%-13.06M	-309.27%-6.11M	10.32%-44.84M
Tax	----	105.86%1.04M	128.30%41.39K	128.30%41.39K	---724	827.00%507.1K	-278.21%-146.28K	-360.02%-146.28K	----	115.08%54.7K
After-tax profit from continuing operations	60.81%-5.53M	53.42%-10.97M	9.26%-19.96M	-6.73%-14.1M	-26.11%-7.71M	47.42%-23.55M	-1,160.09%-22M	-3,507.31%-13.21M	-309.27%-6.11M	11.08%-44.78M
After-tax profit from non-continuing business	----	-129.28%-5.6M	----	----	----	---2.44M	----	----	----	----
Earning after tax	60.81%-5.53M	36.25%-16.57M	9.26%-19.96M	-6.73%-14.1M	-26.11%-7.71M	41.96%-25.99M	-1,160.09%-22M	-3,507.31%-13.21M	-309.27%-6.11M	11.08%-44.78M
Minority shareholders should account for profits from continuing business	----	145.81%3.59M	----	----	----	--1.46M	----	----	----	----
Minority profit	50.77%-1.4M	145.81%3.59M	-617.87%-2.67M	-7,358.70%-2.85M	-2,595.50%-1.83M	157.73%1.46M	-247.70%-371.67K	109.30%39.23K	94.89%-67.91K	-6.95%-2.53M
Shareholders should account for profits from continuing business	----	41.79%-14.56M	----	----	----	---25.01M	----	----	----	----
Shareholders should account for profits from non-continuing business	----	-129.28%-5.6M	----	----	----	---2.44M	----	----	----	----
Profit attributable to shareholders	63.35%-4.12M	26.56%-20.16M	20.03%-17.29M	15.08%-11.25M	2.76%-5.88M	35.03%-27.45M	-1,286.00%-21.63M	-1,736.47%-13.25M	-3,548.93%-6.04M	11.97%-42.26M
Basic earnings per share	62.71%-0.0022	26.90%-0.0106	20.18%-0.0091	15.71%-0.0059	3.13%-0.0031	34.98%-0.0145	-1,240.00%-0.0114	-1,850.00%-0.007	-3,100.00%-0.0032	11.86%-0.0223
Diluted earnings per share		26.90%-0.0106				-0.0145
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	--	--	--	--	--	Unqualified Opinion	--	--	--	Unqualified Opinion
Auditor	--	Fan Chen Certified Public Accountants Co., Ltd.	--	--	--	Fan Chen Certified Public Accountants Co., Ltd.	--	--	--	Fan Chen Certified Public Accountants Co., Ltd.

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

08189 TEDA BIOMEDICAL

TEDA BIOMEDICAL Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target